Legal Assistance Offered For Zantac Cancer Victims
The Food and Drug Administration just recently announced the latest in a series of voluntary recalls by manufacturers of medications such as Zantac containing unacceptable levels of a probable human carcinogen, a substance that could cause cancer.
This is the latest shocking development involving the once-popular, over-the-counter heartburn medication after the FDA and independent scientific research found the medications may contain dangerous levels of N-nitrosodimethylamine (NDMA).
The findings of the dangerous link between taking the heartburn medication and patients developing cancer has generated a large number of Zantac lawsuits on behalf of victims seeking compensatory damages.
As more victims are identified they are seeking help from resources such as the immediate legal assistance offered through nationwide resources such as the network of highly specialized attorneys at Injury Help Desk.
By clicking on Injury Help Desk Zantac victims can find links to free consultations to pursue possible compensation.
The allegations against the drug’s manufacturers are startling. Here is the claim put forth in one such lawsuit, according to the public court file, that is similar to claims made in other actions:
“Since its launch in 1983, every manufacturer of prescription and over-the-counter Zantac has aggressively pushed a poisonous pill into the stream of commerce, while knowing that, when ingested, every single tablet … of Zantac produces levels of NDMA in amounts that exceed the U.S. Food and Drug Administration’s permissible daily limits for the carcinogen by thousands of time.”
WHAT KIND OF CANCERS ARE INVOLVED?
Here is a list of some of the types of cancer that have been blamed in Zantac lawsuits as having been caused by the medication:
- Bladder cancer
- Brain cancer
- Colon cancer
- Stomach cancer
- Esophageal cancer
- Intestinal cancer
- Kidney cancer
- Liver cancer
- Pancreatic cancer
- Testicular cancer
Here is part of the FDA’s warning letter about Zantac and similar products:
The U.S. Food and Drug Administration has learned that some ranitidine medicines, including some products commonly known as the brand-name drug Zantac, contain a nitrosamine impurity called N-nitrosodimethylamine (NDMA) at low levels. NDMA is classified as a probable human carcinogen (a substance that could cause cancer) based on results from laboratory tests. NDMA is a known environmental contaminant and found in water and foods, including meats, dairy products, and vegetables.
The FDA has been investigating NDMA and other nitrosamine impurities in blood pressure and heart failure medicines called Angiotensin II Receptor Blockers (ARBs) since last year. In the case of ARBs, the FDA has recommended numerous recalls as it discovered unacceptable levels of nitrosamines.
The FDA urged patients taking prescription ranitidine to talk to their health care professional about other treatment options and suggested multiple other drugs approved for the same or similar uses as ranitidine.
Zantac is an H2 (histamine-2) blocker which decreases the amount of acid created by the stomach that cause heartburn associated with acid indigestion and sour stomach. Prescription ranitidine is approved for treatment and prevention of ulcers of the stomach and intestines and treatment of gastroesophageal reflux disease, the agency said.
The FDA also said it is working with international regulators and industry partners to determine the source of the impurity in ranitidine that is making it so dangerous to patients and will announce the findings of this investigation.
If you or a loved one were prescribed Zantac or used it to treat heartburn and developed cancer there are legal avenues to be compensated for these health issues. There are free legal consultations available for eligible cases.
However, there may legal time limits involved so immediately contact the nationwide network of highly specialized attorneys at Injury Help Desk for an analysis of your Zantac cancer case.